Financial Ratios Brookfield Corporation
Equities
BN
CA11271J1075
Investment Management & Fund Operators
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
86.38 CAD | -1.11% |
|
-1.16% | +4.55% |
07-09 | Network International LLC agreed to acquire Magnati - Sole Proprietorship L.L.C. | CI |
07-08 | PRESS DIGEST-Financial Times - July 9 | RE |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.76 | 2.39 | 2.52 | 2.22 | 2.64 | |||||
Return on Total Capital | 2.14 | 2.91 | 3.03 | 2.64 | 3.12 | |||||
Return On Equity % | 0.59 | 9.63 | 3.76 | 3.29 | 1.11 | |||||
Return on Common Equity | -0.58 | 10.26 | 4.66 | 2.37 | 1.13 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 24.39 | 18.14 | 17.69 | 20.6 | 27.65 | |||||
SG&A Margin | 0.16 | 0.15 | 0.13 | 0.07 | 0.09 | |||||
EBITDA Margin % | 24.23 | 26.22 | 25.61 | 26.11 | 34.33 | |||||
EBITA Margin % | 17.08 | 19.88 | 19.8 | 19.56 | 26.19 | |||||
EBIT Margin % | 14.99 | 17.99 | 17.56 | 16.85 | 23.35 | |||||
Income From Continuing Operations Margin % | 1.13 | 15.84 | 5.45 | 5.21 | 2.09 | |||||
Net Income Margin % | -0.21 | 5.07 | 2.16 | 1.15 | 0.72 | |||||
Net Avail. For Common Margin % | -0.29 | 4.85 | 2 | 0.98 | 0.53 | |||||
Normalized Net Income Margin | 0.47 | -5.59 | 0.16 | -3.03 | 0.95 | |||||
Levered Free Cash Flow Margin | 0.07 | -5.03 | 0.49 | 0.41 | 1.34 | |||||
Unlevered Free Cash Flow Margin | 7.26 | 1.04 | 7.5 | 10.3 | 13.04 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.19 | 0.21 | 0.23 | 0.21 | 0.18 | |||||
Fixed Assets Turnover | 0.33 | 0.38 | 0.42 | 0.38 | 0.34 | |||||
Receivables Turnover (Average Receivables) | 5.91 | 7.06 | 7.28 | 6.61 | 5.86 | |||||
Inventory Turnover (Average Inventory) | 4.59 | 5.88 | 6.47 | 6.42 | 6.46 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.4 | 1.25 | 1.13 | 0.87 | 1.02 | |||||
Quick Ratio | 0.59 | 0.5 | 0.49 | 0.36 | 0.42 | |||||
Operating Cash Flow to Current Liabilities | 0.25 | 0.16 | 0.15 | 0.09 | 0.11 | |||||
Days Sales Outstanding (Average Receivables) | 61.95 | 51.68 | 50.14 | 55.24 | 62.5 | |||||
Days Outstanding Inventory (Average Inventory) | 79.68 | 62.09 | 56.39 | 56.89 | 56.64 | |||||
Average Days Payable Outstanding | 73.73 | 58.35 | 54.79 | 62.63 | 79.69 | |||||
Cash Conversion Cycle (Average Days) | 67.9 | 55.42 | 51.73 | 49.49 | 39.44 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 129.54 | 139.34 | 159.03 | 146.5 | 150.69 | |||||
Total Debt / Total Capital | 56.43 | 58.22 | 61.39 | 59.43 | 60.11 | |||||
LT Debt/Equity | 111.52 | 114.14 | 127.68 | 111.25 | 118.66 | |||||
Long-Term Debt / Total Capital | 48.58 | 47.69 | 49.29 | 45.13 | 47.33 | |||||
Total Liabilities / Total Assets | 64.32 | 65.54 | 67.85 | 65.67 | 66.28 | |||||
EBIT / Interest Expense | 1.3 | 1.85 | 1.57 | 1.07 | 1.25 | |||||
EBITDA / Interest Expense | 2.11 | 2.7 | 2.28 | 1.65 | 1.83 | |||||
(EBITDA - Capex) / Interest Expense | 1.55 | 1.79 | 1.61 | 1.13 | 1.16 | |||||
Total Debt / EBITDA | 10.46 | 9.16 | 9.24 | 9.63 | 8.18 | |||||
Net Debt / EBITDA | 9.81 | 8.54 | 8.65 | 9.19 | 7.69 | |||||
Total Debt / (EBITDA - Capex) | 14.22 | 13.78 | 13.12 | 14.07 | 12.92 | |||||
Net Debt / (EBITDA - Capex) | 13.33 | 12.85 | 12.29 | 13.43 | 12.14 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -12.48 | 24.75 | 22 | 2.74 | -9.45 | |||||
Gross Profit, 1 Yr. Growth % | -19.04 | 49.35 | 18.96 | 1.55 | 21.54 | |||||
EBITDA, 1 Yr. Growth % | -19.15 | 35.01 | 19.16 | 4.74 | 19.04 | |||||
EBITA, 1 Yr. Growth % | -28.86 | 45.19 | 21.51 | 1.48 | 21.27 | |||||
EBIT, 1 Yr. Growth % | -32.44 | 49.72 | 19.07 | -1.4 | 25.49 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -86.8 | 1.65K | -58.06 | -1.73 | -63.7 | |||||
Net Income, 1 Yr. Growth % | -104.77 | -3.06K | -48.16 | -45.04 | -43.27 | |||||
Normalized Net Income, 1 Yr. Growth % | -73.63 | -1.59K | -103.5 | -2.04K | -128.46 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -106.96 | -2.1K | -50.3 | -48.66 | -49.83 | |||||
Accounts Receivable, 1 Yr. Growth % | -9.13 | 12.05 | 24.91 | 5.11 | -2.59 | |||||
Inventory, 1 Yr. Growth % | 0.86 | 10.18 | 12.51 | -11.14 | -25.89 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 5.81 | 9.89 | 10.64 | 13.54 | -5.55 | |||||
Total Assets, 1 Yr. Growth % | 6.09 | 13.76 | 12.86 | 11.06 | 0.07 | |||||
Tangible Book Value, 1 Yr. Growth % | -32.59 | 12.33 | 218.4 | 17.35 | -7.15 | |||||
Common Equity, 1 Yr. Growth % | 2.67 | 33.18 | -6.16 | 5.22 | 0.48 | |||||
Cash From Operations, 1 Yr. Growth % | 31.81 | -5.6 | 11.14 | -26.1 | 17.04 | |||||
Capital Expenditures, 1 Yr. Growth % | 31.41 | 71.51 | 5.16 | 11.51 | 38.46 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -98.69 | -9.31K | -111.65 | -14.41 | 73.03 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -41.56 | -82.06 | 876.08 | 40.98 | 11.53 | |||||
Dividend Per Share, 1 Yr. Growth % | 11.61 | 9.08 | 7.69 | -50 | 14.29 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.51 | 4.49 | 23.37 | 11.95 | -3.55 | |||||
Gross Profit, 2 Yr. CAGR % | 8.57 | -13.33 | 33.29 | 19.3 | 11.1 | |||||
EBITDA, 2 Yr. CAGR % | 8.64 | 4.48 | 26.84 | 11.72 | 11.66 | |||||
EBITA, 2 Yr. CAGR % | 1.34 | 1.63 | 32.83 | 11.05 | 10.93 | |||||
EBIT, 2 Yr. CAGR % | -1.91 | 0.57 | 33.52 | 8.35 | 11.23 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -69.27 | 52.11 | 171.07 | -35.81 | -40.28 | |||||
Net Income, 2 Yr. CAGR % | -80.66 | 18.87 | 291.7 | -46.62 | -44.16 | |||||
Normalized Net Income, 2 Yr. CAGR % | -25.32 | 98.03 | -27.89 | -17.54 | 135.26 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -76.95 | 17.96 | 215.22 | -49.48 | -49.25 | |||||
Accounts Receivable, 2 Yr. CAGR % | 5.03 | 0.91 | 18.31 | 14.59 | 1.19 | |||||
Inventory, 2 Yr. CAGR % | 21.75 | 5.42 | 11.34 | -0.01 | -18.85 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 13.83 | 7.83 | 10.26 | 12.08 | 3.55 | |||||
Total Assets, 2 Yr. CAGR % | 15.81 | 9.86 | 13.31 | 11.96 | 5.42 | |||||
Tangible Book Value, 2 Yr. CAGR % | 99.47 | -12.98 | 89.12 | 93.3 | 4.39 | |||||
Common Equity, 2 Yr. CAGR % | 11.16 | 16.94 | 11.79 | -0.64 | 2.82 | |||||
Cash From Operations, 2 Yr. CAGR % | 27.15 | 11.55 | 2.43 | -9.37 | -7 | |||||
Capital Expenditures, 2 Yr. CAGR % | 43 | 50.13 | 34.3 | 8.29 | 24.26 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -80.12 | 9.72 | 231 | -68.42 | 59.3 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 52.67 | -67.62 | 25.41 | 270.96 | 27.16 | |||||
Dividend Per Share, 2 Yr. CAGR % | 9.54 | 10.34 | 8.39 | -26.62 | -24.41 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 14.27 | 10.16 | 10.03 | 16.07 | 4.31 | |||||
Gross Profit, 3 Yr. CAGR % | 16.73 | 3.02 | -3.68 | 28.57 | 20.04 | |||||
EBITDA, 3 Yr. CAGR % | 16.86 | 16.8 | 9.16 | 19 | 14.1 | |||||
EBITA, 3 Yr. CAGR % | 12.03 | 14.25 | 7.87 | 21.43 | 14.35 | |||||
EBIT, 3 Yr. CAGR % | 9.42 | 12.94 | 6.39 | 20.68 | 13.79 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -46.24 | 18.27 | -1 | 93.28 | -46.92 | |||||
Net Income, 3 Yr. CAGR % | -54.91 | 3.43 | -9.86 | 103.54 | -45.53 | |||||
Normalized Net Income, 3 Yr. CAGR % | -5.78 | 102.42 | -48.43 | 116.23 | -42.16 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -48.73 | 2.03 | -11.57 | 72.15 | -49.6 | |||||
Accounts Receivable, 3 Yr. CAGR % | 11.94 | 7.32 | 8.35 | 13.74 | 8.55 | |||||
Inventory, 3 Yr. CAGR % | 17.97 | 17.77 | 7.73 | 3.28 | -9.51 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 21.32 | 12.5 | 8.76 | 11.34 | 5.86 | |||||
Total Assets, 3 Yr. CAGR % | 21.27 | 15.12 | 10.85 | 12.56 | 7.84 | |||||
Tangible Book Value, 3 Yr. CAGR % | 19.56 | 64.72 | 34.09 | 61.31 | 51.39 | |||||
Common Equity, 3 Yr. CAGR % | 9.63 | 18.07 | 8.67 | 9.56 | -0.27 | |||||
Cash From Operations, 3 Yr. CAGR % | 27.7 | 15.14 | 11.41 | -8.13 | -1.31 | |||||
Capital Expenditures, 3 Yr. CAGR % | 33.4 | 51.93 | 33.33 | 26.23 | 17.53 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -72.24 | 53.83 | -47.68 | 110.87 | -33.38 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 160.69 | -25.23 | -2.77 | 30.4 | 150.84 | |||||
Dividend Per Share, 3 Yr. CAGR % | 8.73 | 9.39 | 9.45 | -16.25 | -14.94 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 23.57 | 24.92 | 17.83 | 10.87 | 4.38 | |||||
Gross Profit, 5 Yr. CAGR % | 15.87 | 12.17 | 11.91 | 9.25 | 5.38 | |||||
EBITDA, 5 Yr. CAGR % | 16.05 | 21.34 | 20.75 | 14.74 | 10.15 | |||||
EBITA, 5 Yr. CAGR % | 13.68 | 21.21 | 19.93 | 12.96 | 9.08 | |||||
EBIT, 5 Yr. CAGR % | 11.23 | 19.49 | 18.49 | 11.08 | 8.3 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -31.44 | 29.99 | 2.68 | -7.38 | -19.12 | |||||
Net Income, 5 Yr. CAGR % | -43.57 | 19.16 | 7.06 | -20.61 | -25.57 | |||||
Normalized Net Income, 5 Yr. CAGR % | -12.68 | 121.3 | -15.34 | 41.33 | -5.37 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -39.67 | 18.43 | 6.02 | -22.98 | -29.18 | |||||
Accounts Receivable, 5 Yr. CAGR % | 24.48 | 21.42 | 14.45 | 10.17 | 5.42 | |||||
Inventory, 5 Yr. CAGR % | 14.43 | 16.37 | 15.27 | 10.3 | -3.81 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 18.35 | 16.71 | 16.77 | 12.33 | 6.65 | |||||
Total Assets, 5 Yr. CAGR % | 19.76 | 19.59 | 18.02 | 13.84 | 8.65 | |||||
Tangible Book Value, 5 Yr. CAGR % | -11.13 | -7.36 | 43.63 | 75.61 | 21.31 | |||||
Common Equity, 5 Yr. CAGR % | 8 | 13.41 | 10.49 | 10.2 | 6.29 | |||||
Cash From Operations, 5 Yr. CAGR % | 24.5 | 20.63 | 16.92 | 4.62 | 3.65 | |||||
Capital Expenditures, 5 Yr. CAGR % | 29.21 | 36.13 | 33.76 | 32.69 | 29.62 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -61.4 | 16.89 | -25.18 | -18 | -18.32 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -7.58 | -26.57 | 94.54 | 38.89 | 8.25 | |||||
Dividend Per Share, 5 Yr. CAGR % | 8.9 | 8.6 | 8.6 | -6.76 | -5.61 |
- Stock Market
- Equities
- BN Stock
- Financials Brookfield Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition